<!DOCTYPE html><html lang="en" ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta name="theme-color" media="(prefers-color-scheme: light)" content="#f7f7f7"><meta name="theme-color" media="(prefers-color-scheme: dark)" content="#1b1b1e"><meta name="apple-mobile-web-app-capable" content="yes"><meta name="apple-mobile-web-app-status-bar-style" content="black-translucent"><meta name="viewport" content="width=device-width, user-scalable=no initial-scale=1, shrink-to-fit=no, viewport-fit=cover" ><meta name="generator" content="Jekyll v4.3.2" /><meta property="og:title" content="Advances in the Treatment of Oligometastatic Disease" /><meta property="og:locale" content="en" /><meta name="description" content="Rationale and Objectives" /><meta property="og:description" content="Rationale and Objectives" /><link rel="canonical" href="https://clinicaltree.github.io/posts/advances-in-the-treatment-of-oligometastatic-disease/" /><meta property="og:url" content="https://clinicaltree.github.io/posts/advances-in-the-treatment-of-oligometastatic-disease/" /><meta property="og:site_name" content="Radiology Tree" /><meta property="og:type" content="article" /><meta property="article:published_time" content="2016-02-29T17:00:00+00:00" /><meta name="twitter:card" content="summary" /><meta property="twitter:title" content="Advances in the Treatment of Oligometastatic Disease" /><meta name="twitter:site" content="@twitter_username" /><meta name="google-site-verification" content="RFHVRgQqK0eGjftEMCTDhsDrR8cJ_ZYcfCX52gXW8KM" /> <script type="application/ld+json"> {"@context":"https://schema.org","@type":"BlogPosting","dateModified":"2023-04-10T03:59:08+00:00","datePublished":"2016-02-29T17:00:00+00:00","description":"Rationale and Objectives","headline":"Advances in the Treatment of Oligometastatic Disease","mainEntityOfPage":{"@type":"WebPage","@id":"https://clinicaltree.github.io/posts/advances-in-the-treatment-of-oligometastatic-disease/"},"url":"https://clinicaltree.github.io/posts/advances-in-the-treatment-of-oligometastatic-disease/"}</script><title>Advances in the Treatment of Oligometastatic Disease | Radiology Tree</title><link rel="apple-touch-icon" sizes="180x180" href="/assets/img/favicons/apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="/assets/img/favicons/favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="/assets/img/favicons/favicon-16x16.png"><link rel="manifest" href="/assets/img/favicons/site.webmanifest"><link rel="shortcut icon" href="/assets/img/favicons/favicon.ico"><meta name="apple-mobile-web-app-title" content="Radiology Tree"><meta name="application-name" content="Radiology Tree"><meta name="msapplication-TileColor" content="#da532c"><meta name="msapplication-config" content="/assets/img/favicons/browserconfig.xml"><meta name="theme-color" content="#ffffff"><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://fonts.gstatic.com" crossorigin><link rel="dns-prefetch" href="https://fonts.gstatic.com" crossorigin><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://cdn.jsdelivr.net" ><link rel="dns-prefetch" href="https://cdn.jsdelivr.net" ><link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Lato&family=Source+Sans+Pro:wght@400;600;700;900&display=swap"><link rel="preconnect" href="https://www.google-analytics.com" crossorigin="use-credentials"><link rel="dns-prefetch" href="https://www.google-analytics.com"><link rel="preconnect" href="https://www.googletagmanager.com" crossorigin="anonymous"><link rel="dns-prefetch" href="https://www.googletagmanager.com"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/css/bootstrap.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.2.1/css/all.min.css"><link rel="stylesheet" href="/assets/css/style.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/magnific-popup@1.1.0/dist/magnific-popup.min.css"> <script src="https://cdn.jsdelivr.net/npm/jquery@3.6.1/dist/jquery.min.js"></script> <script type="text/javascript"> class ModeToggle { static get MODE_KEY() { return "mode"; } static get MODE_ATTR() { return "data-mode"; } static get DARK_MODE() { return "dark"; } static get LIGHT_MODE() { return "light"; } static get ID() { return "mode-toggle"; } constructor() { if (this.hasMode) { if (this.isDarkMode) { if (!this.isSysDarkPrefer) { this.setDark(); } } else { if (this.isSysDarkPrefer) { this.setLight(); } } } let self = this; /* always follow the system prefers */ this.sysDarkPrefers.addEventListener('change', () => { if (self.hasMode) { if (self.isDarkMode) { if (!self.isSysDarkPrefer) { self.setDark(); } } else { if (self.isSysDarkPrefer) { self.setLight(); } } self.clearMode(); } self.notify(); }); } /* constructor() */ get sysDarkPrefers() { return window.matchMedia("(prefers-color-scheme: dark)"); } get isSysDarkPrefer() { return this.sysDarkPrefers.matches; } get isDarkMode() { return this.mode === ModeToggle.DARK_MODE; } get isLightMode() { return this.mode === ModeToggle.LIGHT_MODE; } get hasMode() { return this.mode != null; } get mode() { return sessionStorage.getItem(ModeToggle.MODE_KEY); } /* get the current mode on screen */ get modeStatus() { if (this.isDarkMode || (!this.hasMode && this.isSysDarkPrefer)) { return ModeToggle.DARK_MODE; } else { return ModeToggle.LIGHT_MODE; } } setDark() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.DARK_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.DARK_MODE); } setLight() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.LIGHT_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.LIGHT_MODE); } clearMode() { $('html').removeAttr(ModeToggle.MODE_ATTR); sessionStorage.removeItem(ModeToggle.MODE_KEY); } /* Notify another plugins that the theme mode has changed */ notify() { window.postMessage({ direction: ModeToggle.ID, message: this.modeStatus }, "*"); } flipMode() { if (this.hasMode) { if (this.isSysDarkPrefer) { if (this.isLightMode) { this.clearMode(); } else { this.setLight(); } } else { if (this.isDarkMode) { this.clearMode(); } else { this.setDark(); } } } else { if (this.isSysDarkPrefer) { this.setLight(); } else { this.setDark(); } } this.notify(); } /* flipMode() */ } /* ModeToggle */ const modeToggle = new ModeToggle(); </script><body data-topbar-visible="true"><div id="sidebar" class="d-flex flex-column align-items-end"><div class="profile-wrapper text-center"><div id="avatar"> <a href="/" class="mx-auto"> <img src="https://storage.googleapis.com/clinicalpub.com/images/favicon.png" alt="avatar" onerror="this.style.display='none'"> </a></div><div class="site-title"> <a href="/">Radiology Tree</a></div><div class="site-subtitle font-italic">Update every day the best and the lastest articles, books, journals, clinical cases, videos, images... for radiologist</div></div><ul class="w-100"><li class="nav-item"> <a href="/" class="nav-link"> <i class="fa-fw fas fa-home ml-xl-3 mr-xl-3 unloaded"></i> <span>HOME</span> </a><li class="nav-item"> <a href="/categories/" class="nav-link"> <i class="fa-fw fas fa-stream ml-xl-3 mr-xl-3 unloaded"></i> <span>CATEGORIES</span> </a><li class="nav-item"> <a href="/tags/" class="nav-link"> <i class="fa-fw fas fa-tag ml-xl-3 mr-xl-3 unloaded"></i> <span>TAGS</span> </a><li class="nav-item"> <a href="/archives/" class="nav-link"> <i class="fa-fw fas fa-archive ml-xl-3 mr-xl-3 unloaded"></i> <span>ARCHIVES</span> </a><li class="nav-item"> <a href="/about/" class="nav-link"> <i class="fa-fw fas fa-info-circle ml-xl-3 mr-xl-3 unloaded"></i> <span>ABOUT</span> </a></ul><div class="sidebar-bottom mt-auto d-flex flex-wrap justify-content-center align-items-center"> <button class="mode-toggle btn" aria-label="Switch Mode"> <i class="fas fa-adjust"></i> </button> <span class="icon-border"></span> <a href="https://github.com/clinicaltree" aria-label="github" target="_blank" rel="noopener noreferrer"> <i class="fab fa-github"></i> </a> <a href="https://twitter.com/twitter_username" aria-label="twitter" target="_blank" rel="noopener noreferrer"> <i class="fab fa-twitter"></i> </a> <a href="javascript:location.href = 'mailto:' + ['clinicalpub.team','gmail.com'].join('@')" aria-label="email" > <i class="fas fa-envelope"></i> </a> <a href="/feed.xml" aria-label="rss" > <i class="fas fa-rss"></i> </a></div></div><div id="topbar-wrapper"><div id="topbar" class="container d-flex align-items-center justify-content-between h-100 pl-3 pr-3 pl-md-4 pr-md-4"> <span id="breadcrumb"> <span> <a href="/"> Home </a> </span> <span>Advances in the Treatment of Oligometastatic Disease</span> </span> <i id="sidebar-trigger" class="fas fa-bars fa-fw"></i><div id="topbar-title"> Post</div><i id="search-trigger" class="fas fa-search fa-fw"></i> <span id="search-wrapper" class="align-items-center"> <i class="fas fa-search fa-fw"></i> <input class="form-control" id="search-input" type="search" aria-label="search" autocomplete="off" placeholder="Search..."> </span> <span id="search-cancel" >Cancel</span></div></div><div id="main-wrapper" class="d-flex justify-content-center"><div id="main" class="container pl-xl-4 pr-xl-4"><div class="row"><div id="core-wrapper" class="col-12 col-lg-11 col-xl-9 pr-xl-4"><div class="post pl-1 pr-1 pl-md-2 pr-md-2"><h1 data-toc-skip>Advances in the Treatment of Oligometastatic Disease</h1><div class="post-meta text-muted"> <span> Posted <em class="" data-ts="1456765200" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Feb 29, 2016 </em> </span> <span> Updated <em class="" data-ts="1681099148" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Apr 10, 2023 </em> </span><div class="d-flex justify-content-between"> <span> By <em> <a href="">Steven P. Rowe MD PhD</a> </em>, <em> <a href="">Hazem Hawasli MD</a> </em>, <em> <a href="">Elliot K. Fishman MD</a> </em>, <em> <a href="">Pamela T. Johnson MD</a> </em> </span><div> <span class="readtime" data-toggle="tooltip" data-placement="bottom" title="1296 words"> <em>7 min</em> read</span></div></div></div><div class="post-content"><h2 id="rationale-and-objectives"><span class="mr-2">Rationale and Objectives</span><a href="#rationale-and-objectives" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>An ever-expanding body of biological, genetic, and clinical evidence has brought to light the presence of the oligometastatic state of cancer, which is considered between localized disease and widespread metastases. Indeed, in some patients with oligometastatic disease, curative therapy is possible.</p><h2 id="conclusions"><span class="mr-2">Conclusions</span><a href="#conclusions" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>For select cancer histologies, aggressive focal therapy of oligometastatic lesions is already the clinical standard of care (i.e. colorectal cancer and sarcomas), while for other tumor types the evidence is still emerging (i.e. prostate, breast, etc.). It is increasingly important, therefore, for the radiologist interpreting oncology patients’ staging or restaging examinations to be aware of those diseases for which targeted therapy of oligometastases may be undertaken to effectively guide such management. The improved imaging resolution provided by technological advances promise to aid in the detection of subtle sites of disease to ensure the identification of patients with oligometastases amenable to targeted treatment.</p><h2 id="introduction"><span class="mr-2">Introduction</span><a href="#introduction" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>In a landmark paper in 1995, Hellman and Weichselbaum postulated the oligometastatic state of oncologic disease, in which patients may harbor a limited number of metastatic lesions. This state was viewed as existing on a continuum between localized and diffuse metastatic diseases, with oligometastic patients potentially receiving improved systemic control or even cure of their disease from treatment directed at these discrete metastatic foci. Indeed, there is increasing evidence on the molecular and genetic levels that oligometastatic disease is a distinct entity from diffusely metastatic disease, with the metastatic cells in oligometastases displaying a phenotype that lacks some of the elements necessary to bring about widespread metastases . This recognition results in a profoundly important change from the dogma that a small number of identifiable metastatic lesions necessarily connote widespread systemic disease and a stage of cancer only amenable to systemic chemotherapy.</p><p>In light of this shifting perception about the nature of metastatic cancer, for those patients in whom there are a small number of discretely identifiable lesions, it is becoming increasingly incumbent upon the interpreting radiologist to delineate each of those lesions. An approach in which only an index lesion is specifically commented upon when a small number of other lesions are present may be inadequate in certain clinical contexts. Indeed, the radiologist should be cognizant of the need to guide treatment in cases of oligometastatic disease, which can include a variety of local therapies such as radiation, surgery, or cryotherapy. Although a number of definitions of oligometastatic disease have been suggested, and refinement of the concept of oligometastasis may eventually arrive at different definitions for different diseases, most commonly five or fewer distinct lesions are considered oligometastases .</p><p>This opinion piece discusses the malignancies in which aggressive treatment of oligometastic disease is already widely clinically accepted, as well as those in which there is emerging evidence that such treatment may be beneficial. We also refer the reader to an excellent and comprehensive review by Reyes and Pienta that discusses the biology of oligometastsic disease and the current clinical trials ongoing within this realm.</p><h2 id="colorectal-cancer"><span class="mr-2">Colorectal Cancer</span><a href="#colorectal-cancer" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Oligometastatic colorectal cancer involving the liver represents a prototype for the aggressive treatment of a small number of metastatic lesions, with liver resection taking place before, after, or at the time of resection of the primary . Thermal and radiofrequency ablation can also be used in the treatment of oligometastatic disease to the liver. Treatment of oligometastatic colorectal cancer to the liver can be curative in some patients . In any case of colorectal cancer staging or restaging with cross-sectional imaging, it is of utmost importance to examine the liver for any suspicious lesion(s) and to accurately identify their locations within the liver, unless such lesions are widespread or diffuse.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="prostate-cancer"><span class="mr-2">Prostate Cancer</span><a href="#prostate-cancer" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="renal-cell-carcinoma-rcc"><span class="mr-2">Renal Cell Carcinoma (RCC)</span><a href="#renal-cell-carcinoma-rcc" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="sarcomas"><span class="mr-2">Sarcomas</span><a href="#sarcomas" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="lung-cancer"><span class="mr-2">Lung Cancer</span><a href="#lung-cancer" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="other-cancer-types"><span class="mr-2">Other Cancer Types</span><a href="#other-cancer-types" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="conclusion"><span class="mr-2">Conclusion</span><a href="#conclusion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="references"><span class="mr-2">References</span><a href="#references" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><ul><li><p>1. Hellman S., Weichselbaum R.R.: Oligometastases. J Clin Oncol 1995; 13: pp. 8-10.</p><li><p>2. Corbin K.S., Hellman S., Weichselbaum R.R.: Extracranial oligometastases: a subset of metastases curable with stereotactic radiotherapy. J Clin Oncol 2013; 31: pp. 1384-1390.</p><li><p>3. Reyes D.K., Pienta K.J.: The biology and treatment of oligometastatic cancer. Oncotarget 2015; 6: pp. 8491-8524.</p><li><p>4. Kelly M.E., Spolverato G., Lê G.N., et. al.: Synchronous liver metastasis: a network meta-analysis review comparing classical, combined, and liver-first surgical strategies. J Surg Oncol 2015; 111: pp. 341-351.</p><li><p>5. Tomlinson J.S., Jarnagin E.R., DeMatteo R.P., et. al.: Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol 2007; 25: pp. 4575-4580.</p><li><p>6. Salah S., Watanabe K., Welter S., et. al.: Colorectal cancer pulmonary metastases: pooled analysis and construction of a clinical lung metastasectomy prognostic model. Ann Oncol 2012; 23: pp. 2649-2655.</p><li><p>7. Neeff H., Hörth W., Makowiec F., et. al.: Outcome after resection of hepatic and pulmonary metastases of colorectal cancer. J Gastrointest Surg 2009; 13: pp. 1813-1820.</p><li><p>8. Siegel R.L., Miller K.D., Jemal A.: Cancer statistics, 2015. CA Cancer J Clin 2015; 65: pp. 5-29.</p><li><p>9. Decaestecker K., De Meerleer G., Ameye F., et. al.: Surveillance or metastasis-directed Therapy for OligoMetastatic Prostate cancer recurrence (STOMP): study protocol for a randomized phase II trial. BMC Cancer 2014; 14: pp. 671.</p><li><p>10. Aoun F., Peltier A., Velthoven R.: A comprehensive review of contemporary role of local treatment of the primary tumor and/or metastases in metastatic prostate cancer. Biomed Res Int 2014; 2014: pp. 501213.</p><li><p>11. Conde Moreno A.J., Ferrer Albiach C., Muelas Soria R., et. al.: Oligometastases in prostate cancer: restaging stage IV cancers and new radiotherapy options. Radiat Oncol 2014; 9: pp. 258.</p><li><p>12. Cho S.Y., Gage K.L., Mease R.C., et. al.: Biodistribution, tumor detection, and radiation dosimetry of 18 F-DCFBC, a low-molecular-weight inhibitor of prostate-specific membrane antigen, in patients with metastatic prostate cancer. J Nucl Med 2012; 53: pp. 1883-1891.</p><li><p>13. Szabo Z., Mena E., Rowe S.P., et. al.: Initial evaluation of [ 18 F]DCFPyL for prostate-specific membrane antigen (PSMA)-targeted PET imaging of prostate cancer. Mol Imaging Biol 2015; 17: pp. 565-574.</p><li><p>14. Dietlein M., Kobe C., Kuhnert G., et. al.: Comparison of [ 18 F]DCFPyL and [ 68 Ga]Ga-PSMA-HBED-CC for PSMA-PET imaging in patients with relapsed prostate cancer. Mol Imaging Biol 2015; 17: pp. 575-584.</p><li><p>15. Dabestani S., Marconi L., Hofmann F., et. al.: Local treatments for metastases of renal cell carcinoma: a systematic review. Lancet Oncol 2014; 15: pp. e549-e561.</p><li><p>16. Falk A.T., Moureau-Zabotto L., Ouali M., et. al.: Effect on survival of local ablative treatment of metastases from sarcomas: a study of the French sarcoma group. Clin Oncol (R Coll Radiol) 2015; 27: pp. 48-55.</p><li><p>17. Ashworth A., Rodrigues G., Boldt G., et. al.: Is there an oligometastatic state in non-small cell lung cancer? A systematic review of the literature. Lung Cancer 2013; 82: pp. 197-203.</p><li><p>18. Salama J.K., Schild S.E.: Radiation therapy for oligometastatic non-small cell lung cancer. Cancer Metastasis Reg 2015; 34: pp. 183-193.</p><li><p>19. Porte H., Siat J., Guibert B., et. al.: Resection of adrenal metastases from non-small cell lung cancer: a multicenter study. Ann Thorac Surg 2001; 71: pp. 981-985.</p><li><p>20. Pagani O., Senkus E., Wood W., et. al.: International guidelines for management of metastatic breast cancer: can metastatic breast cancer be cured?. J Natl Cancer Inst 2010; 102: pp. 456-463.</p><li><p>21. Di Lascio S., Pagani O.: Oligometastatic breast cancer: a shift from palliative to potentially curative treatment?. Breast Care (Basel) 2014; 9: pp. 7-14.</p><li><p>22. Essner R., Lee J.H., Wanek L.A., et. al.: Contemporary surgical treatment of advanced stage melanoma. Arch Surg 2004; 139: pp. 961-966.</p></ul></div><div class="post-tail-wrapper text-muted"><div class="post-meta mb-3"> <i class="far fa-folder-open fa-fw mr-1"></i> <a href='/categories/academic-radiology/'>Academic Radiology</a>, <a href='/categories/volume-23/'>Volume 23</a>, <a href='/categories/issue-3/'>Issue 3</a></div><div class="post-tags"> <i class="fa fa-tags fa-fw mr-1"></i> <a href="/tags/journals/" class="post-tag no-text-decoration" >Journals</a> <a href="/tags/general-radiology/" class="post-tag no-text-decoration" >General Radiology</a></div><div class="post-tail-bottom d-flex justify-content-between align-items-center mt-3 pt-5 pb-2"><div class="license-wrapper"> This post is licensed under <a href="https://creativecommons.org/licenses/by/4.0/"> CC BY 4.0 </a> by the author.</div><div class="share-wrapper"> <span class="share-label text-muted mr-1">Share</span> <span class="share-icons"> <a href="https://twitter.com/intent/tweet?text=Advances%20in%20the%20Treatment%20of%20Oligometastatic%20Disease%20-%20Radiology%20Tree&url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fadvances-in-the-treatment-of-oligometastatic-disease%2F" data-toggle="tooltip" data-placement="top" title="Twitter" target="_blank" rel="noopener" aria-label="Twitter"> <i class="fa-fw fab fa-twitter"></i> </a> <a href="https://www.facebook.com/sharer/sharer.php?title=Advances%20in%20the%20Treatment%20of%20Oligometastatic%20Disease%20-%20Radiology%20Tree&u=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fadvances-in-the-treatment-of-oligometastatic-disease%2F" data-toggle="tooltip" data-placement="top" title="Facebook" target="_blank" rel="noopener" aria-label="Facebook"> <i class="fa-fw fab fa-facebook-square"></i> </a> <a href="https://t.me/share/url?url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fadvances-in-the-treatment-of-oligometastatic-disease%2F&text=Advances%20in%20the%20Treatment%20of%20Oligometastatic%20Disease%20-%20Radiology%20Tree" data-toggle="tooltip" data-placement="top" title="Telegram" target="_blank" rel="noopener" aria-label="Telegram"> <i class="fa-fw fab fa-telegram"></i> </a> <i id="copy-link" class="fa-fw fas fa-link small" data-toggle="tooltip" data-placement="top" title="Copy link" data-title-succeed="Link copied successfully!"> </i> </span></div></div></div></div></div><div id="panel-wrapper" class="col-xl-3 pl-2 text-muted"><div class="access"><div id="access-lastmod" class="post"><div class="panel-heading">Recently Updated</div><ul class="post-content pl-0 pb-1 ml-1 mt-2"><li><a href="/posts/neurometabolites-alteration-in-the-acute-phase-of-mild-traumatic-brain-injury-mtbi/">Neurometabolites Alteration in the Acute Phase of Mild Traumatic Brain Injury (mTBI)</a><li><a href="/posts/reinforcing-the-importance-and-feasibility-of-implementing-a-low-dose-protocol-for-ct-guided-biopsie/">Reinforcing the Importance and Feasibility of Implementing a Low-dose Protocol for CT-guided Biopsies</a><li><a href="/posts/rethinking-the-pgy-1-basic-clinical-year/">Rethinking the PGY-1 Basic Clinical Year</a><li><a href="/posts/single-injection-dual-phase-cone-beam-ct-dp-cbct-vascular-anatomy-assessment-and-occult-nodule-det/">Single Injection Dual-Phase Cone Beam CT (DP-CBCT) Vascular Anatomy Assessment and Occult Nodule Detection; Have We Reached the Focus?</a><li><a href="/posts/the-yellow-scale-is-superior-to-the-gray-scale-for-detecting-acute-ischemic-stroke-on-a-monitor-disp/">The Yellow Scale Is Superior to the Gray Scale for Detecting Acute Ischemic Stroke on a Monitor Display in Computed Tomography</a></ul></div><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="toc-wrapper" class="pl-0 pr-4 mb-5"><div class="panel-heading pl-3 pt-2 mb-2">Contents</div><nav id="toc"></nav></div><script src="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.js"></script></div></div><div class="row"><div id="tail-wrapper" class="col-12 col-lg-11 col-xl-9 pl-3 pr-3 pr-xl-4 mt-5"><div id="related-posts" class="mb-2 mb-sm-4"><h3 class="pt-2 mb-4 ml-1" data-toc-skip>Further Reading</h3><div class="card-deck mb-4"><div class="card"> <a href="/posts/assessment-of-background-parenchymal-enhancement-and-lesion-kinetics-in-breast-mri-of-brca-1-2-mutat/"><div class="card-body"> <em class="small" data-ts="1456765200" data-df="ll" > Feb 29, 2016 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Assessment of Background Parenchymal Enhancement and Lesion Kinetics in Breast MRI of BRCA 1/2 Mutation Carriers Compared to Matched Controls Using Quantitative Kinetic Analysis</h3><div class="text-muted small"><p> Rationale and Objectives To investigate whether quantitative kinetic analysis of lesions and background parenchyma in breast magnetic resonance imaging can elucidate differences between BRCA carri...</p></div></div></a></div><div class="card"> <a href="/posts/automated-assessment-of-left-ventricular-function-and-mass-using-heart-deformation-analysis/"><div class="card-body"> <em class="small" data-ts="1456765200" data-df="ll" > Feb 29, 2016 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Automated Assessment of Left Ventricular Function and Mass Using Heart Deformation Analysis</h3><div class="text-muted small"><p> Rationale and Objectives To assess the performance of automated quantification of left ventricular function and mass based on heart deformation analysis (HDA) in asymptomatic older adults. Materi...</p></div></div></a></div><div class="card"> <a href="/posts/bone-marrow-lipid-profiles-from-peripheral-skeleton-as-potential-biomarkers-for-osteoporosis-a1-h-m/"><div class="card-body"> <em class="small" data-ts="1456765200" data-df="ll" > Feb 29, 2016 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Bone Marrow Lipid Profiles from Peripheral Skeleton as Potential Biomarkers for Osteoporosis A1 H-MR Spectroscopy Study</h3><div class="text-muted small"><p> Rationale and Objectives To characterize the lipidic profile of bone marrow in the calcaneus and femoral neck of healthy, osteopenic, and osteoporotic women, by using magnetic resonance spectrosco...</p></div></div></a></div></div></div><div class="post-navigation d-flex justify-content-between"> <a href="/posts/volumetric-arterial-spin-labeled-perfusion-imaging-of-the-kidneys-with-a-three-dimensional-fast-spin/" class="btn btn-outline-primary" prompt="Older"><p>Volumetric Arterial Spin-labeled Perfusion Imaging of the Kidneys with a Three-dimensional Fast Spin Echo Acquisition</p></a> <a href="/posts/assessment-of-background-parenchymal-enhancement-and-lesion-kinetics-in-breast-mri-of-brca-1-2-mutat/" class="btn btn-outline-primary" prompt="Newer"><p>Assessment of Background Parenchymal Enhancement and Lesion Kinetics in Breast MRI of BRCA 1/2 Mutation Carriers Compared to Matched Controls Using Quantitative Kinetic Analysis</p></a></div></div></div></div><div id="search-result-wrapper" class="d-flex justify-content-center unloaded"><div class="col-12 col-sm-11 post-content"><div id="search-hints"><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="search-results" class="d-flex flex-wrap justify-content-center text-muted mt-3"></div></div></div></div><footer><div class="container pl-lg-4 pr-lg-4"><div class="d-flex justify-content-between align-items-center text-muted ml-md-3 mr-md-3"><div class="footer-left"><p class="mb-0"> © 2023 <a href="https://twitter.com/username">Clinical Team</a>. <span data-toggle="tooltip" data-placement="top" title="Except where otherwise noted, the blog posts on this site are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) License by the author.">Some rights reserved.</span></p></div><div class="footer-right"><p class="mb-0">Using the <a href="https://jekyllrb.com" target="_blank" rel="noopener">Jekyll</a> theme <a href="https://github.com/cotes2020/jekyll-theme-chirpy" target="_blank" rel="noopener">Chirpy</a>.</p></div></div></div></footer><div id="mask"></div><a id="back-to-top" href="#" aria-label="back-to-top" class="btn btn-lg btn-box-shadow" role="button"> <i class="fas fa-angle-up"></i> </a><div id="notification" class="toast" role="alert" aria-live="assertive" aria-atomic="true" data-animation="true" data-autohide="false"><div class="toast-header"> <button type="button" class="ml-2 ml-auto close" data-dismiss="toast" aria-label="Close"> <span aria-hidden="true">&times;</span> </button></div><div class="toast-body text-center pt-0"><p class="pl-2 pr-2 mb-3">A new version of content is available.</p><button type="button" class="btn btn-primary" aria-label="Update"> Update </button></div></div><script src="https://cdn.jsdelivr.net/npm/simple-jekyll-search@1.10.0/dest/simple-jekyll-search.min.js"></script> <script> SimpleJekyllSearch({ searchInput: document.getElementById('search-input'), resultsContainer: document.getElementById('search-results'), json: '/assets/js/data/search.json', searchResultTemplate: '<div class="pl-1 pr-1 pl-sm-2 pr-sm-2 pl-lg-4 pr-lg-4 pl-xl-0 pr-xl-0"> <a href="{url}">{title}</a><div class="post-meta d-flex flex-column flex-sm-row text-muted mt-1 mb-1"> {categories} {tags}</div><p>{snippet}</p></div>', noResultsText: '<p class="mt-5">Oops! No results found.</p>', templateMiddleware: function(prop, value, template) { if (prop === 'categories') { if (value === '') { return `${value}`; } else { return `<div class="mr-sm-4"><i class="far fa-folder fa-fw"></i>${value}</div>`; } } if (prop === 'tags') { if (value === '') { return `${value}`; } else { return `<div><i class="fa fa-tag fa-fw"></i>${value}</div>`; } } } }); </script> <script src="https://cdn.jsdelivr.net/combine/npm/magnific-popup@1.1.0/dist/jquery.magnific-popup.min.js,npm/lazysizes@5.3.2/lazysizes.min.js,npm/clipboard@2.0.11/dist/clipboard.min.js"></script> <script src="https://cdn.jsdelivr.net/combine/npm/dayjs@1.11.6/dayjs.min.js,npm/dayjs@1.11.6/locale/en.min.js,npm/dayjs@1.11.6/plugin/relativeTime.min.js,npm/dayjs@1.11.6/plugin/localizedFormat.min.js"></script> <script defer src="/assets/js/dist/post.min.js"></script> <script src="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/js/bootstrap.bundle.min.js"></script> <script defer src="/app.js"></script> <script defer src="https://www.googletagmanager.com/gtag/js?id=G-L66SLQK23K"></script> <script> document.addEventListener("DOMContentLoaded", function(event) { window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-L66SLQK23K'); }); </script>
